NCT04381156 is a clinical trial in Markers in Plasma and Urine, sponsored by Heinrich-Heine University, Duesseldorf.

Who is sponsoring NCT04381156?

NCT04381156 is sponsored by Heinrich-Heine University, Duesseldorf.

What condition does NCT04381156 study?

NCT04381156 studies Markers in Plasma and Urine.

Is NCT04381156 still recruiting?

NCT04381156 is currently status unknown. Last updated 13 July 2020.

Last reviewed 2020-07-13 · How we verify

NCT04381156

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MicroRNAs in Renal Recovery - Pilot Study

Status unknown Last updated 13 July 2020

What this trial tests

trial in Markers in Plasma and Urine in 70 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
31 December 2018

31 December 2020

Quick facts

Lead sponsor	Heinrich-Heine University, Duesseldorf
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 January 2018
Primary completion	31 December 2018
Estimated completion	31 December 2020
Sites	1 location across Germany

Conditions studied

Markers in Plasma and Urine — all drugs for Markers in Plasma and Urine →

Sponsor

Heinrich-Heine University, Duesseldorf

Who can join

Adults 18 to 90, any sex, with Markers in Plasma and Urine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this Pilot study, the potential of noncoding RNAs in renal recovery from acute kidney injury will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Heinrich-Heine University, Duesseldorf trials

Trials by the same sponsor.

NCT04993508 — Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Co · NA · not yet recruiting
NCT07385482 — Chronic and Acute Cardiovascular Diseases in Elderly Intensive Care Patients · not yet recruiting
NCT07455097 — COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) · active not recruiting
NCT07254663 — GEL & MEDication Dysphagia · recruiting
NCT06313944 — German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04381156 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heinrich-Heine University, Duesseldorf
Last refreshed: 13 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04381156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing